Search Results - Liu, Huaxiang
- Showing 1 - 17 results of 17
-
1
-
2
-
3
Effects of Exogenous Galanin on Neuropathic Pain State and Change of Galanin and Its Receptors in DRG and SDH after Sciatic Nerve-Pinch Injury in Rat by Xu, Xiaofeng, Yang, Xiangdong, Zhang, Ping, Chen, Xiuying, Liu, Huaxiang, Li, Zhenzhong
Published 2012Text -
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
Long noncoding RNA profiling revealed differentially expressed lncRNAs associated with disease activity in PBMCs from patients with rheumatoid arthritis by Yuan, Min, Wang, Shujun, Yu, Lijie, Qu, Bo, Xu, Liming, Liu, Lining, Sun, Huanxia, Li, Chunxian, Shi, Yanjun, Liu, Huaxiang
Published 2017Text -
12
Maintenance of Patient-Reported Outcomes in Baricitinib-Treated Patients with Moderate-to-Severe Active Rheumatoid Arthritis: Post Hoc Analyses from Two Phase 3 Trials by Sholter, Dalton, Wu, Jianmin, Jia, Bochao, Zhang, Hong, Griffing, Kirstin, Birt, Julie, Reis, Paulo Jorge Simoes, Liu, Huaxiang, Bingham, Clifton O.
Published 2022Text -
13
Efficacy and safety of HLX01 in patients with moderate-to-severe rheumatoid arthritis despite methotrexate therapy: a phase 3 study by Zeng, Xiaofeng, Liu, Ju, Liu, Xiumei, Wu, Lijun, Liu, Yi, Liao, Xiangping, Liu, Huaxiang, Hu, Jiankang, Lu, Xin, Chen, Linjie, Xu, Jian, Jiang, Zhenyu, Lu, Fu-ai, Wu, Huaxiang, Li, Ying, Wang, Qingyu, Zhu, Jun
Published 2022Text -
14
Comparison of the Efficacy and Safety of Adalimumab (Humira) and the Adalimumab Biosimilar Candidate (HS016) in Chinese Patients with Active Ankylosing Spondylitis: A Multicenter,... by Su, Jinmei, Li, Mengtao, He, Lan, Zhao, Dongbao, Wan, Weiguo, Liu, Yi, Xu, Jianhua, Xu, Jian, Liu, Huaxiang, Jiang, Lindi, Wu, Huaxiang, Zuo, Xiaoxia, Huang, Cibo, Liu, Xiumei, Li, Fen, Zhang, Zhiyi, Liu, Xiangyuan, Dong, Lingli, Li, Tianwang, Chen, Haiying, Li, Jingyang, He, Dongyi, Lu, Xin, Huang, Anbin, Tao, Yi, Wang, Yanyan, Zhang, Zhuoli, Wei, Wei, Li, Xiaofeng, Zeng, Xiaofeng
Published 2020Text -
15
Changes in Efficacy Indicators for Adalimumab Biosimilar Candidate (HS016) for the Treatment of Active Ankylosing Spondylitis at Various Time Points by Su, Jinmei, Li, Mengtao, He, Lan, Zhao, Dongbao, Wan, Weiguo, Liu, Yi, Xu, Jianhua, Xu, Jian, Liu, Huaxiang, Jiang, Lindi, Wu, Huaxiang, Zuo, Xiaoxia, Huang, Cibo, Liu, Xiumei, Li, Fen, Zhang, Zhiyi, Liu, Xiangyuan, Dong, Lingli, Li, Tianwang, Chen, Haiying, Li, Jingyang, He, Dongyi, Lu, Xin, Huang, Anbin, Tao, Yi, Wang, Yanyan, Zhang, Zhuoli, Wei, Wei, Li, Xiaofeng, Zeng, Xiaofeng
Published 2020Text -
16
Evaluation of adalimumab biosimilar candidate (HS016) in Chinese patients with active ankylosing spondylitis based on a health survey: sub-analysis of a phase 3 study by Su, Jinmei, Li, Mengtao, He, Lan, Zhao, Dongbao, Wan, Weiguo, Liu, Yi, Xu, Jianhua, Xu, Jian, Liu, Huaxiang, Jiang, Lindi, Wu, Huaxiang, Zuo, Xiaoxia, Huang, Cibo, Liu, Xiumei, Li, Fen, Zhang, Zhiyi, Liu, Xiangyuan, Dong, Lingli, Li, Tianwang, Chen, Haiying, Li, Jingyang, He, Dongyi, Lu, Xin, Huang, Anbin, Tao, Yi, Wang, Yanyan, Zhang, Zhuoli, Wei, Wei, Li, Xiaofeng, Zeng, Xiaofeng
Published 2021Text -
17
Prevalence and risk factors of active tuberculosis in patients with rheumatic diseases: a multi-center, cross-sectional study in China by Liu, Xiaoqing, Zhang, Lifan, Zhang, Fengchun, Zeng, Xiaofeng, Zhao, Yan, Wang, Qian, Liu, Shengyun, Zuo, Xiaoxia, Zhang, Zhiyi, Wu, Huaxiang, Chen, Sheng, Li, Hongbin, Zhu, Ping, Wu, Lijun, Qi, Wencheng, Liu, Yi, Zhang, Miaojia, Liu, Huaxiang, Xu, Dong, Zheng, Wenjie, Zhang, Yueqiu, Shi, Xiaochun, Han, Lishuai, Zhou, Yaou, Zhao, Yanping, Wang, Wenwen, Li, Ting, Tie, Ning, Zhang, Kui, Luo, Cainan, Gong, Baoqi, Zhao, Yi, Lv, Chengyin, Song, Lijun, Wu, Qingjun, Fei, Yunyun, Zhang, Lei, Luo, Hui, Sun, Jiaying, Xue, Jing, Gu, Liyang, Wang, Jing, Han, Qing, Yimaity, Kuerbanjiang, Zhou, Jiaxin, Zhao, Lidan, Bian, Sainan, Qi, Wufang, Li, Yanhong, Zhu, Yujing, Han, Huijun, Liao, Susu, Liu, Gaifen
Published 2021Text